Analyst Ratings for Vera Therapeutics (VERA)
VERA Rating Summary
VERA Price Target Summary
- Highest: $100.00 (Cantor Fitzgerald)
- Lowest: $60.00 (Jefferies)
- Average: $80.91
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$80.91 (+139.7%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
Avg. $ Target:
$80.91 (+139.7%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/10/2026 | Wolfe Research » Updated 6/2/2026 |
Andy Chen | Upgrade | Outperform (Peerperform) |
88.00 (N/A) |
38.97 (33.75) |
-13.39% | Details |
| 10/16/2025 | BofA Securities » Updated 3/9/2026 |
Dina Ramadane | New Coverage | Buy (N/A) |
66.00 (N/A) |
31.00 (33.75) |
8.87% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


